Form 4: Fulgent Genetics CFO Paul Kim Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Fulgent Genetics CFO Paul Kim sold 733 shares of common stock on August 27, 2024, to satisfy tax withholding obligations related to vesting restricted stock units.
Summary
- On August 27, 2024, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., sold 733 shares of the company's common stock.
- The sale was executed at a weighted-average price of $22.833 per share, with individual transactions ranging from $22.72 to $22.915.
- The purpose of the sale was to cover tax withholding obligations arising from the vesting of restricted stock units granted to Mr. Kim on February 23, 2023.
- Following the transaction, Mr. Kim directly owns 211,155 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't indicate a change in the executive's confidence in the company.
Industry Context
This is a routine transaction where a company executive sells shares to cover tax obligations related to stock-based compensation. It's a common practice and doesn't necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| February 23, 2023 | Date of restricted stock unit grant to Paul Kim. |
| February 27, 2023 | Original Form 4 filing date for the restricted stock unit grant. |
| August 27, 2024 | Date of the share sale transaction. |
| August 29, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.